
Investor relations
Cinclus Pharma
Investors
Cinclus Pharma is a Swedish clinical stage pharma company developing small molecules for the treatment of gastric acid related diseases. Our lead candidate linaprazan glurate is being developed for treatment of severe gastroesophageal reflux disease (GERD).